Bcl-xL blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells

Journal of Neurochemistry

Volumn 89, Issue 1, 2004, Pages 124-133

  Jordán, Joaquín ^a   Galindo, María F ^a   Tornero, Daniel ^a   González García, Carmen ^a   Ceña, Valentín ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Apoptosis; Caspases; Mitochondria; Neurodegeneration; Parkinson; ROS

Indexed keywords

CASPASE 3; CYTOCHROME C; FREE RADICAL; OXIDOPAMINE; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL VIABILITY; CONTROLLED STUDY; ELECTRON TRANSPORT; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MEMBRANE CONDUCTANCE; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 1842614395     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02299.x     Document Type: Article

References (62)

1. Adams J. M. and Cory S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Berger K., Przedborski S. and Cadet J. L. (1991) Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res. Bull. 26, 301-307.
3. Blum D., Torch S., Nissou M. F., Benabid A. L. and Verna J. M. (2000) Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci. Lett. 283, 193-196.
4. Boix J., Llecha N., Yuste V. J. and Comella J. X. (1997) Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 36, 811-821.
5. Bojes H. K., Datta K., Xu J., Chin A., Simonian P., Nunez G. and Kehrer J. P. (1997) Bcl-xL overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal. Biochem. J. 325, 315-319.
6. Borutaite V. and Brown G. C. (2001) Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett. 500, 114-118.
7. Campo M. L., Kinnally K. W. and Tedeschi H. (1992) The effect of antimycin A on mouse liver inner mitochondrial membrane channel activity. J. Biol. Chem. 267, 8123-8127.
8. Cao G., Pei W., Ge H., Liang Q., Luo Y., Sharp F. R., Lu A., Ran R., Graham S. H. and Chen J. (2002) In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22, 5423-5431.
9. von Coelln R., Kugler S., Bahr M., Weller M., Dichgans J. and Schulz J. B. (2001) Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77, 263-273.
10. Decker G. L. and Greenawalt J. W. (1977) Ultrastructural and biochemical studies of mitoplasts and outer membranes derived from French-pressed mitochondria. Advances in mitochondrial subfractionation. J. Ultrastruct. Res. 59, 44-56.
11. 2 receptor and redox-transducer in gene activation. Cell 111, 471-481.
12. 2+-dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons. Biochem. J. 283, 41-50.
13. Ellerby L. M., Ellerby H. M., Park S. M., Holleran A. L., Murphy A. N., Fiskum G., Kane D. J., Testa M. P., Kayalar C. and Bredesen D. E. (1996) Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67, 1259-1267.
14. Galindo M. F., Jordan J., Gonzalez-Garcia C. and Ceña V. (2003) Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation. J. Neurochem. 84, 1066-1073.
15. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
16. Halestrap A. P., McStay G. P. and Clarke S. J. (2002) The permeability transition pore complex: another view. Biochimie 84, 153-166.
17. Heikkila R. E., Hess A. and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224, 1451-1453.
18. Jeon B. S., Jackson-Lewis V. and Burke R. E. (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4, 131-137.
19. Jordan J., Galindo M. F. and Miller R. J. (1997) Role of calpain- and interleukin-1β converting enzyme-like proteases in the β -amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. 68, 1612-1621.
20. Jordan J., Galindo M. F., Calvo S., Gonzalez-Garcia C. and Ceña V. (2000) Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. Br. J. Pharmacol. 130, 1496-1504.
21. Jordan J., Galindo M. F., Tomero D., Benavides A., Gonzalez C., Agapito M. T., Gonzalez-Garcia C. and Ceña V. (2002) Superoxide anions mediate veratridine-induced cytochrome c release and caspase activity in bovine chromaffin cells. Br. J. Pharmacol. 137, 993-1000.
22. Kinnally K. W., Lohret T. A., Campo M. L. and Mannella C. A. (1996) Perspectives on the mitochondrial multiple conductance channel. J. Bioenerg. Biomembr. 28, 115-123.
23. Kirpekar S. M., Nobiletti J. and Trifaro J. M. (1983) Effect of 6-hydroxydopamine on bovine adrenal chromaffin cells in culture. Br. J. Pharmacol. 79, 947-952.
24. Kirsch M. and De Groot H. (2001) NAD(P)H, a directly operating antioxidant? FASEB J. 15, 1569-1574.
25. Kroemer G. and Reed J. C. (2000) Mitochondrial control of cell death. Nat. Med. 6, 513-519.
26. Kushnareva Y. E., Campo M. L., Kinnally K. W. and Sokolove P. M. (1999a) Signal presequences increase mitochondrial permeability and open the multiple conductance channel. Arch. Biochem. Biophys. 366, 107-115.
27. 2+ concentration. Arch. Biochem. Biophys. 363, 155-162.
28. Le D. A., Wu Y., Huang Z. et al. (2002) Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl Acad. Sci. USA 99, 15188-15193.
29. Lohret T. A., Murphy R. C., Drgoñ T. and Kinnally K. W. (1996) Activity of the mitochondrial multiple conductance channel is independent of the adenine nucleotide translocator. J. Biol. Chem. 271, 4846-4849.
30. Maestre I., Jordan J., Calvo S., Reig J. A., Cena V., Soria B., Prentki M. and Roche E. (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the β-cell line INS-1. Endocrinology 144, 335-345.
31. Mannick J. B., Schonhoff C., Papeta N., Ghafourifar P., Szibor M., Fang K. and Gaston B. (2001) S-Nitrosylation of mitochondrial caspases. J. Cell Biol. 154, 1111-1116.
32. Maruyama W., Oya-Ito T., Shamoto-Nagai M., Osawa T. and Naoi M. (2002) Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells. Neurosci. Lett. 321, 29-32.
33. Mayes P. (1993) The pentose phosphate pathway and other pathways of hexose metabolism, in Harper's Biochemistry, 23th edn, (Murray R., Granner D., Mayes P. and Rodwell V., eds), p. 201. Appleton & Lange, Norwalk, CT.
34. Murphy R. C., Schneider E. and Kinnally K. W. (2001) Overexpression of Bcl-2 suppresses the calcium activation of a mitochondrial megachannel. FEBS Lett. 497, 73-76.
35. Nagata S. and Golstein P. (1995) The Fas death factor. Science 267, 1449-1456.
36. Nakamura K., Bindokas V. P., Marks J. D., Wright D. A., Frim D. M., Miller R. J. and Kang U. J. (2000) The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. Mol. Pharmacol. 58, 271-278.
37. Natsume A., Mata M., Goss J., Huang S., Wolfe D., Oligino T., Glorioso J. and Fink D. J. (2001) Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp. Neurol. 169, 231-238.
38. Nicholson D. W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042.
39. Nicklas W. J., Vyas I. and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
40. Nie G., Cao Y. and Zhao B. (2002) Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox. Rep. 7, 171-177.
41. Nunez G., Benedict M. A., Hu Y. and Inohara N. (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17, 3237-3245.
42. Offen D., Beart P. M., Cheung N. S., Pascoe C. J., Hochman A., Gorodin S., Melamed E., Bernard R. and Bernard O. (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA 95, 5789-5794.
43. Ouyang Y. B., Carriedo S. G. and Giffard R. G. (2002) Effect of Bcl-xL overexpression on reactive oxygen species, intracellular calcium, and mitochondrial membrane potential following injury in astrocytes. Free Radic. Biol. Med. 33, 544-551.
44. Reed J. C., Jurgensmeier J. M. and Matsuyama S. (1998) Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366, 127-137.
45. Rover Junior L., Fernandes J. C., de Oliveira Neto G., Kubota L. T., Katekawa E. and Serrano S. H. (1998) Study of NADH stability using ultraviolet-visible spectrophotometric analysis and factorial design. Anal. Biochem. 260, 50-55.
46. Saner A. and Thoenen H. (1971) Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmacol. 7, 147-154.
47. Sauer H. and Oertel W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415.
48. Seitz G., Stegmann H. B., Jager H. H., Schlude H. M., Wolburg H., Roginsky V. A., Niethammer D. and Bruchelt G. (2000) Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine. J. Neurochem. 75, 511-520.
49. Shimizu E., Hashimoto K., Komatsu N. and Iyo M. (2002) Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43, 434-443.
50. Shrieve D. C., Bump E. A. and Rice G. C. (1998) Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J. Biol. Chem. 263, 14107-14114.
51. Steinman H. M. (1995) The Bcl-2 oncoprotein functions as a prooxidant. J. Biol. Chem. 270, 3487-3490.
52. Steller H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1462.
53. Storch A., Kaftan A., Burkhardt K. and Schwarz J. (2000) 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. J. Neural Transm. 107, 281-293.
54. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
55. Thornberry N. A. (1998) Caspases: key mediators of apoptosis. Chem. Biol. 5, R97-R103.
56. Tiffany-Castiglioni E., Saneto R. P., Proctor P. H. and Perez-Polo J. R. (1982) Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. Biochem. Pharmacol. 31, 181-188.
57. Tsujimoto Y. (1989) Stress-resistance conferred by high level of bcl-2α protein in human B lymphoblastoid cell. Oncogene 4, 1331-1336.
58. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
59. Walkinshaw G. and Waters C. M. (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 95, 2458-2464.
60. Xu R., Liu J., Chen X., Xu F., Xie Q., Yu H., Guo Q., Zhou X. and Jin Y. (2001) Ribozyme-mediated inhibition of caspase-3 activity reduces apoptosis induced by 6-hydroxydopamine in PC12 cells. Brain Res. 899, 10-19.
61. Yamada M., Oligino T., Mata M., Goss J. R., Glorioso J. C. and Fink D. J. (1999) Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc. Natl Acad. Sci. USA 96, 4078-4083.
62. Young P. R., Connors White A. L. and Dzido G. A. (1994) Kinetic analysis of the intracellular conjugation of monochlorobimane by IC-21 murine macrophage glutathione-S-transferase. Biochim. Biophys. Acta 1201, 461-465.